|
|||||
|
|
Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis |
|
| Authors: | Namita Joshi Hrishikesh Kale Shelby Corman Tim Wert Kala Hill Amer M. Zeidan |
| Affiliation: | 1. Real-world Evidence/Data Analytics Center of Excellence, Pharmerit International LP, Bethesda, MD;2. Market Access, Taiho Oncology, Princeton, NJ;3. Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven, New Haven, CT |
| Abstract: | |
| Keywords: | Healthcare resource use Health economics Persistence Real-world studies SEER database |
| 本文献已被 ScienceDirect 等数据库收录！ | |